Furthermore, HCC LSECs express plasmalemma vesicle-associated protein (PLVAP), making them less permeable and potentially limiting the entry of lymphocytes and tumour-derived antigens (Rantakari et al., 2015). The gene discussed is PLVAP; the disease is hepatocellular carcinoma.